Compare GFI & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GFI | WAT |
|---|---|---|
| Founded | 1887 | 1958 |
| Country | South Africa | United States |
| Employees | 6560 | N/A |
| Industry | Precious Metals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.5B | 33.6B |
| IPO Year | N/A | 1996 |
| Metric | GFI | WAT |
|---|---|---|
| Price | $40.47 | $341.01 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 17 |
| Target Price | $52.71 | ★ $379.19 |
| AVG Volume (30 Days) | ★ 2.5M | 1.1M |
| Earning Date | 03-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.41% | N/A |
| EPS Growth | N/A | ★ 0.47 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $49.67 | $104.66 |
| Revenue Next Year | N/A | $10.40 |
| P/E Ratio | $25.02 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $21.57 | $275.05 |
| 52 Week High | $61.52 | $414.15 |
| Indicator | GFI | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 39.77 | 57.47 |
| Support Level | $36.96 | $340.09 |
| Resistance Level | $43.15 | $356.41 |
| Average True Range (ATR) | 1.45 | 11.94 |
| MACD | -0.38 | -0.16 |
| Stochastic Oscillator | 22.81 | 71.91 |
Gold Fields Ltd is a producer of gold and is a holder of gold reserves and resources in South Africa, Ghana, Australia and Peru. In Peru, the company also produces copper. The company is involved in underground and surface gold and surface copper mining and silver and related activities, including exploration, extraction, processing and smelting. It conducts underground and surface mining operations at St. Ives, underground-only operations at Agnew, Granny Smith and South Deep and surface-only open pit mining at Damang, Tarkwa and Cerro Corona. The company's revenues are derived from the sale of gold that it produces.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.